GlaxoSmithKline Pharmaceuticals Ltd. (GLAXO)
Market Closed
4 Mar, 10:00
XNSE XNSE Primary MSE ₹
2,487. 00
-45.6
-1.8%
₹
416.26B Market Cap
60.37 P/E Ratio
48% Div Yield
7,527 Volume
40.12 Eps
₹ 2,532.6
Previous Close Day Range
2,481 2,512.1
Year Range
2,220.3 3,515.7
Want to track GLAXO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
GLAXO earnings report is expected in 68 days (11 May 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 9.89 |
| | | - | 12.84 |
| | | 17.16 | 4.17 |
GLAXO Earnings Reports FAQ
What is the earnings per share (EPS) for GLAXO?
The current EPS is 40.12.
What is the company's earnings growth rate?
Over the past 9 years, the earnings growth rate has been approximately 13.13%, reflecting the GLAXO's performance and XNSE market conditions.
When is the next earnings release date?
The next earnings release is expected to be on 2026-05-11, based on the GLAXO's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for GlaxoSmithKline Pharmaceuticals Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for GLAXO at this time, as GlaxoSmithKline Pharmaceuticals Ltd has no recent EPS data to calculate it.
